研究报告 |
|
|
|
|
基于单细胞转录组的基因富集方法分析星形胶质细胞与阿尔茨海默病的关系* |
乔隆1,廖亚金2,潘瑞远2,袁增强1,2,**() |
1 安徽医科大学基础医学院 合肥 230032 2 军事科学院军事医学研究院军事认知与脑科学研究所 北京 100850 |
|
Study of the Relationship Between Astrocytes and Alzheimer’s Disease by Gene Set Enrichment Analysis Based on Single-cell RNA Sequence |
QIAO Long1,LIAO Ya-jin2,PAN Rui-yuan2,YUAN Zeng-qiang1,2,**() |
1 School of Basic Medicine, Anhui Medical University, Hefei 230032,China 2 Institute of Military Cognition and Brain Sciences, Academy of Military Medical Sciences, Beijing 100850, China |
引用本文:
乔隆,廖亚金,潘瑞远,袁增强. 基于单细胞转录组的基因富集方法分析星形胶质细胞与阿尔茨海默病的关系*[J]. 中国生物工程杂志, 2022, 42(5): 18-26.
QIAO Long,LIAO Ya-jin,PAN Rui-yuan,YUAN Zeng-qiang. Study of the Relationship Between Astrocytes and Alzheimer’s Disease by Gene Set Enrichment Analysis Based on Single-cell RNA Sequence. China Biotechnology, 2022, 42(5): 18-26.
链接本文:
https://manu60.magtech.com.cn/biotech/CN/10.13523/j.cb.2112014
或
https://manu60.magtech.com.cn/biotech/CN/Y2022/V42/I5/18
|
[1] |
Cai Z Y, Wan C Q, Liu Z. Astrocyte and Alzheimer’s disease. Journal of Neurology, 2017, 264(10): 2068-2074.
doi: 10.1007/s00415-017-8593-x
|
[2] |
Wakabayashi K, Miki Y. Deposition and clearance of β-amyloid in the brain. Brain and Nerve, 2013, 65(12): 1433-1444.
|
[3] |
Choi S S, Lee S R, Lee H J. Neurorestorative role of stem cells in Alzheimer’s disease: astrocyte involvement. Current Alzheimer Research, 2016, 13(4): 419-427.
doi: 10.2174/156720501304160314162812
|
[4] |
Tarczyluk M A, Nagel D A, Rhein Parri H, et al. Amyloid β 1-42 induces hypometabolism in human stem cell-derived neuron and astrocyte networks. Journal of Cerebral Blood Flow and Metabolism, 2015, 35(8): 1348-1357.
doi: 10.1038/jcbfm.2015.58
pmid: 25853906
|
[5] |
Stipursky J, Romão L, Tortelli V, et al. Neuron-Glia signaling: implications for astrocyte differentiation and synapse formation. Life Sciences, 2011, 89(15-16): 524-531.
doi: 10.1016/j.lfs.2011.04.005
pmid: 21569780
|
[6] |
Carter S F, Herholz K, Rosa-Neto P, et al. Astrocyte biomarkers in Alzheimer’s disease. Trends in Molecular Medicine, 2019, 25(2): 77-95.
doi: 10.1016/j.molmed.2018.11.006
|
[7] |
Mathys H, Davila-Velderrain J, Peng Z, et al. Single-cell transcriptomic analysis of Alzheimer’s disease. Nature, 2019, 570 (7761): 332-337.
doi: 10.1038/s41586-019-1195-2
|
[8] |
Zhou Y, Song W M, Andhey P S, et al. Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer’s disease. Nature Medicine, 2020, 26 (1): 131-142.
doi: 10.1038/s41591-019-0695-9
|
[9] |
Zhang X X, Lan Y J, Xu J Y, et al. CellMarker: a manually curated resource of cell markers in human and mouse. Nucleic Acids Research, 2018, 47(D1): D721-D728.
doi: 10.1093/nar/gky900
|
[10] |
Weise C M, Chen K W, Chen Y H, et al. Left lateralized cerebral glucose metabolism declines in amyloid-β positive persons with mild cognitive impairment. NeuroImage: Clinical, 2018, 20: 286-296.
doi: 10.1016/j.nicl.2018.07.016
|
[11] |
Croteau E, Castellano C A, Fortier M, et al. A cross-sectional comparison of brain glucose and ketone metabolism in cognitively healthy older adults, mild cognitive impairment and early Alzheimer’s disease. Experimental Gerontology, 2018, 107: 18-26.
doi: S0531-5565(17)30228-0
pmid: 28709938
|
[12] |
Arnold S E, Arvanitakis Z, Macauley-Rambach S L, et al. Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums. Nature Reviews Neurology, 2018, 14(3): 168-181.
doi: 10.1038/nrneurol.2017.185
|
[13] |
Butterfield D A, di Domenico F, Barone E. Elevated risk of type 2 diabetes for development of Alzheimer disease: a key role for oxidative stress in brain. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2014, 1842(9): 1693-1706.
doi: 10.1016/j.bbadis.2014.06.010
|
[14] |
Neth B J, Craft S. Insulin resistance and Alzheimer’s disease: bioenergetic linkages. Frontiers in Aging Neuroscience, 2017, 9: 345.
doi: 10.3389/fnagi.2017.00345
|
[15] |
Haughey N J, Mattson M P. Alzheimer’s amyloid beta-peptide enhances ATP/gap junction-mediated calcium-wave propagation in astrocytes. Neuromolecular Medicine, 2003, 3(3): 173-180.
pmid: 12835512
|
[16] |
Siracusa R, Fusco R, Cuzzocrea S. Astrocytes: role and functions in brain pathologies. Frontiers in Pharmacology, 2019, 10: 1114.
doi: 10.3389/fphar.2019.01114
pmid: 31611796
|
[17] |
Siino V, Jensen P, James P, et al. Obesogenic diets cause alterations on proteins and theirs post-translational modifications in mouse brains. Nutrition and Metabolic Insights, 2021, 14: 11786388211012405.
|
[18] |
Sultana R, Boyd-Kimball D, Cai J, et al. Proteomics analysis of the Alzheimer’s disease hippocampal proteome. Journal of Alzheimer’s Disease: JAD, 2007, 11(2): 153-164.
|
[19] |
Meier-Ruge W, Iwangoff P, Reichlmeier K. Neurochemical enzyme changes in Alzheimer’s and Pick’s disease. Archives of Gerontology and Geriatrics, 1984, 3(2): 161-165.
pmid: 6089677
|
[20] |
Kim J, Han J, Jang Y, et al. High-capacity glycolytic and mitochondrial oxidative metabolisms mediate the growth ability of glioblastoma. International Journal of Oncology, 2015, 47(3): 1009-1016.
doi: 10.3892/ijo.2015.3101
|
[21] |
Wang F, Xu C S, Chen W H, et al. Identification of blood-based glycolysis gene associated with Alzheimer’s disease by integrated bioinformatics analysis. Journal of Alzheimer’s Disease: JAD, 2021, 83(1): 163-178.
|
[22] |
Shindyapina A V, Komarova T V, Sheshukova E V, et al. The antioxidant cofactor alpha-lipoic acid may control endogenous formaldehyde metabolism in mammals. Frontiers in Neuroscience, 2017, 11: 651.
doi: 10.3389/fnins.2017.00651
pmid: 29249928
|
[23] |
Sathe G, Na C H, Renuse S, et al. Quantitative proteomic profiling of cerebrospinal fluid to identify candidate biomarkers for Alzheimer’s disease. PROTEOMICS - Clinical Applications, 2019, 13(4): 1800105.
doi: 10.1002/prca.201800105
|
[24] |
El Kadmiri N, Slassi I, El Moutawakil B, et al. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and Alzheimer’s disease. Pathologie-biologie, 2014, 62(6): 333-336.
doi: 10.1016/j.patbio.2014.08.002
|
[25] |
Rahman M R, Islam T, Shahjaman M, et al. Discovering biomarkers and pathways shared by Alzheimer’s disease and ischemic stroke to identify novel therapeutic targets. Medicina (Kaunas, Lithuania), 2019, 55(5): 191.
|
[26] |
Shen L M, Chen C, Yang A C, et al. Redox proteomics identification of specifically carbonylated proteins in the hippocampi of triple transgenic Alzheimer’s disease mice at its earliest pathological stage. Journal of Proteomics, 2015, 123: 101-113.
doi: 10.1016/j.jprot.2015.04.005
|
[27] |
Butterfield D A, Halliwell B. Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease. Nature Reviews Neuroscience, 2019, 20 (3): 148-160.
doi: 10.1038/s41583-019-0132-6
pmid: 30737462
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|